Rodrigo D Portugal1, Marcia Garnica, Marcio Nucci. 1. University Hospital, Hematology Service, Universidade Federal do Rio de Janeiro, Cidade Universitária, Rio de Janeiro, Brazil.
Abstract
PURPOSE: Patients with prolonged and profound neutropenia are at high risk to develop invasive mold infections (IMIs). We developed an index (D-index) that combines duration and severity of neutropenia. The aim of this study was to test the D-index as a predictor of IMI. PATIENTS AND METHODS: The D-index was based on a graph plotting the absolute neutrophil counts during neutropenia and was the area over the neutrophil curve. We tested the D-index in 11 patients with acute myeloid leukemia (AML) who developed IMI during neutropenia and 33 AML patients without IMI (controls). We also calculated a cumulative D-index (c-D-index), defined as the cumulative D-index from the start of neutropenia until the date of the first clinical manifestation of IMI in patient cases. We compared the D-index and c-D-index with duration of neutropenia and defined a cutoff for IMI using the receiver operating characteristic (ROC) curve. RESULTS: The median duration of neutropenia and profound neutropenia of patient cases were significantly higher compared with controls (P = .002 and P = .001, respectively), as were the D-index (P < .001) and c-D-index (P = .02). The D-index and c-D-index performed better than duration of neutropenia in ROC curve analysis. For a cutoff point of 5,800 of the c-D-index, the sensitivity and specificity were 91% and 58%, respectively, and for a prevalence of IMI of 5%, 10%, and 15%, the negative predictive values were 99%, 98%, and 97%, respectively. CONCLUSION: The high negative predictive value of the c-D-index may be of help in defining different risks for IMI in febrile neutropenic patients.
PURPOSE:Patients with prolonged and profound neutropenia are at high risk to develop invasive mold infections (IMIs). We developed an index (D-index) that combines duration and severity of neutropenia. The aim of this study was to test the D-index as a predictor of IMI. PATIENTS AND METHODS: The D-index was based on a graph plotting the absolute neutrophil counts during neutropenia and was the area over the neutrophil curve. We tested the D-index in 11 patients with acute myeloid leukemia (AML) who developed IMI during neutropenia and 33 AMLpatients without IMI (controls). We also calculated a cumulative D-index (c-D-index), defined as the cumulative D-index from the start of neutropenia until the date of the first clinical manifestation of IMI in patient cases. We compared the D-index and c-D-index with duration of neutropenia and defined a cutoff for IMI using the receiver operating characteristic (ROC) curve. RESULTS: The median duration of neutropenia and profound neutropenia of patient cases were significantly higher compared with controls (P = .002 and P = .001, respectively), as were the D-index (P < .001) and c-D-index (P = .02). The D-index and c-D-index performed better than duration of neutropenia in ROC curve analysis. For a cutoff point of 5,800 of the c-D-index, the sensitivity and specificity were 91% and 58%, respectively, and for a prevalence of IMI of 5%, 10%, and 15%, the negative predictive values were 99%, 98%, and 97%, respectively. CONCLUSION: The high negative predictive value of the c-D-index may be of help in defining different risks for IMI in febrile neutropenicpatients.
Authors: Cybele Lara R Abad; Brian Lahr; John C O'Horo; Prakhar Vijayvargiya; Randall C Walker; William J Hogan; Aaron J Tande Journal: Int J Hematol Date: 2019-11-11 Impact factor: 2.490
Authors: Jason N Barreto; Kristen B McCullough; Candy S Peskey; Ross A Dierkhising; Kristin C Mara; Michelle A Elliott; Dennis A Gastineau; Aref Al-Kali; Naseema Gangat; Louis Letendre; William J Hogan; Mark R Litzow; Mrinal M Patnaik Journal: Leuk Lymphoma Date: 2017-05-09
Authors: Ibrahim Aldoss; Sanjeet Dadwal; Jianying Zhang; Bernard Tegtmeier; Matthew Mei; Shukaib Arslan; Monzr M Al Malki; Amandeep Salhotra; Haris Ali; Ahmed Aribi; Karamjeet Sandhu; Samer Khaled; David Snyder; Ryotaro Nakamura; Anthony S Stein; Stephen J Forman; Guido Marcucci; Vinod Pullarkat Journal: Blood Adv Date: 2019-12-10